There have been 50 recent insider transactions recorded for Certara, Inc. (CERT), including 13 buys and 31 sells. Total insider buying was valued at $200K and total insider selling at $1.33M.
Notable insiders with recent activity include Pedersen Leif E, Gallagher John E, Aspbury Robert. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CERT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Pedersen Leif E |
President, Chief Commercal Off |
Option Exercise (Sell) |
7,852 |
- |
- |
- |
| 2026-04-01 |
Gallagher John E |
Chief Financial Officer |
Option Exercise (Sell) |
12,633 |
- |
- |
- |
| 2026-04-01 |
Aspbury Robert |
President, Predictive Tech |
Option Exercise (Sell) |
7,852 |
- |
- |
- |
| 2026-04-01 |
Anhalt Rona |
Chief Human Resources Officer |
Tax Withholding of RSU |
3,062 |
$5.70 |
$17.45K |
11,883 |
| 2026-04-01 |
Corcoran Daniel |
SVP and General Counsel |
Tax Withholding of RSU |
5,751 |
$5.70 |
$32.78K |
21,319 |
| 2026-04-01 |
Mckemey Adrian |
President, Drug Dev. Solutions |
Tax Withholding of RSU |
2,642 |
$5.70 |
$15.06K |
8,207 |
| 2026-02-27 |
Bedi Arjun |
Director |
RSU Award |
5,547 |
- |
- |
5,547 |
| 2026-02-24 |
Bedi Arjun |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-01-01 |
Resnick Jon Matthew |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-11 |
Feehery William F |
Chief Executive Officer |
Informative Buy |
24,096 |
$8.30 |
$200K |
2,360,769 |
| 2025-09-09 |
Pedersen Leif E |
President, Chief Commercal Off |
Informative Sell |
51,224 |
$10.92 |
$559.37K |
73,979 |
| 2025-05-30 |
Anhalt Rona |
Chief Human Resources Officer |
Tax Withholding of RSU |
1,965 |
$11.40 |
$22.4K |
5,181 |
| 2025-05-30 |
Corcoran Daniel |
SVP and General Counsel |
Tax Withholding of RSU |
2,298 |
$11.40 |
$26.2K |
5,642 |
| 2025-05-21 |
Cashman James E Iii |
Other: Chairman |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Broshy Eran |
Other: Chairman |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Walsh Matthew M |
Director |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Collins Cynthia |
Director |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Crane Rosemary A |
Director |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Killefer Nancy |
Director |
Option Exercise (Sell) |
11,928 |
- |
- |
- |
| 2025-05-21 |
Reynders John V W |
Director |
Option Exercise (Sell) |
10,709 |
- |
- |
- |
| 2025-05-20 |
Feehery William F |
Chief Executive Officer |
RSU Award |
187,144 |
- |
- |
187,144 |
| 2025-05-20 |
Pedersen Leif E |
President, Chief Commercal Off |
RSU Award |
45,566 |
- |
- |
45,566 |
| 2025-05-20 |
Gallagher John E |
Chief Financial Officer |
RSU Award |
68,348 |
- |
- |
68,348 |
| 2025-05-20 |
Aspbury Robert |
President, Predictive Tech |
RSU Award |
45,566 |
- |
- |
45,566 |
| 2025-05-20 |
Anhalt Rona |
Chief Human Resources Officer |
RSU Award |
29,292 |
- |
- |
29,292 |
| 2025-05-20 |
Corcoran Daniel |
SVP and General Counsel |
RSU Award |
32,547 |
- |
- |
32,547 |
| 2025-05-20 |
Mckemey Adrian |
President, Drug Dev. Solutions |
RSU Award |
32,547 |
- |
- |
32,547 |
| 2025-04-01 |
Feehery William F |
Chief Executive Officer |
Option Exercise (Sell) |
36,580 |
- |
- |
- |
| 2025-04-01 |
Pedersen Leif E |
President, Chief Commercal Off |
Option Exercise (Sell) |
8,647 |
- |
- |
- |
| 2025-04-01 |
Gallagher John E |
President, Chief Commercal Off |
Option Exercise (Sell) |
14,663 |
- |
- |
- |
| 2025-04-01 |
Aspbury Robert |
President, Predictive Tech |
Option Exercise (Sell) |
8,647 |
- |
- |
- |
| 2025-03-03 |
Mckemey Adrian |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-16 |
Reynders John V W |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-16 |
Reynders John V W |
Director |
RSU Award |
10,709 |
- |
- |
10,709 |
| 2024-10-07 |
Smith Patrick F |
President, Drug Dev Solutions |
Informative Sell |
5,409 |
$11.03 |
$59.66K |
50,091 |
| 2024-10-04 |
Smith Patrick F |
President, Drug Dev Solutions |
Option Exercise |
7,151 |
- |
- |
14,303 |
| 2024-09-09 |
Pedersen Leif E |
President, Chief Commercal Off |
Informative Sell |
51,224 |
$11.29 |
$578.32K |
99,704 |
| 2024-07-01 |
Aspbury Robert |
President, Scientific Software |
Tax Withholding of RSU |
862 |
$13.85 |
$11.94K |
289,314 |
| 2024-06-01 |
Anhalt Rona |
Chief Human Resources Officer |
RSU Award |
21,440 |
- |
- |
21,440 |
| 2024-06-01 |
Corcoran Daniel |
SVP and General Counsel |
RSU Award |
23,822 |
- |
- |
23,822 |
| 2024-05-23 |
Anhalt Rona |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-05-21 |
Cashman James E Iii |
Other: Chairman |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-21 |
Broshy Eran |
Director |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-21 |
Walsh Matthew M |
Director |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-21 |
Collins Cynthia |
Director |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-21 |
Crane Rosemary A |
Director |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-21 |
Killefer Nancy |
Director |
Option Exercise (Sell) |
8,663 |
- |
- |
- |
| 2024-05-20 |
Corcoran Daniel |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-04-02 |
Smith Patrick F |
President, Drug Dev Solutions |
Informative Sell |
422 |
$17.77 |
$7.5K |
50,091 |
| 2024-04-01 |
Feehery William F |
Chief Executive Officer |
Option Exercise (Sell) |
36,580 |
- |
- |
36,580 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
